melatonin has been researched along with Eosinophilia-Myalgia Syndrome in 3 studies
Eosinophilia-Myalgia Syndrome: A complex systemic syndrome with inflammatory and autoimmune components that affect the skin, fascia, muscle, nerve, blood vessels, lung, and heart. Diagnostic features generally include EOSINOPHILIA, myalgia severe enough to limit usual activities of daily living, and the absence of coexisting infectious, autoimmune or other conditions that may induce eosinophilia. Biopsy of affected tissue reveals a microangiopathy associated with diffuse inflammation involving connective tissue. (From Spitzer et al., J Rheumatol Suppl 1996 Oct;46:73-9; Blackburn WD, Semin Arthritis Rheum 1997 Jun;26(6):788-93)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Six of these contaminants were identified as analogues of impurities found in contaminated L-tryptophan (an over-the-counter dietary supplement) associated with the eosinophilia-myalgia syndrome (EMS) epidemic that occurred in the United States during 1989." | 7.70 | Structural characterization of contaminants found in commercial preparations of melatonin: similarities to case-related compounds from L-tryptophan associated with eosinophilia-myalgia syndrome. ( Gleich, GJ; Mishra, PK; Naylor, S; Tomlinson, AJ; Williamson, BL, 1998) |
| " Six of these contaminants were identified as analogues of impurities found in contaminated L-tryptophan (an over-the-counter dietary supplement) associated with the eosinophilia-myalgia syndrome (EMS) epidemic that occurred in the United States during 1989." | 3.70 | Structural characterization of contaminants found in commercial preparations of melatonin: similarities to case-related compounds from L-tryptophan associated with eosinophilia-myalgia syndrome. ( Gleich, GJ; Mishra, PK; Naylor, S; Tomlinson, AJ; Williamson, BL, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Williamson, BL | 2 |
| Tomlinson, AJ | 2 |
| Naylor, S | 3 |
| Gleich, GJ | 3 |
| Mishra, PK | 1 |
3 other studies available for melatonin and Eosinophilia-Myalgia Syndrome
| Article | Year |
|---|---|
Contaminants in commercial preparations of melatonin.
Topics: Drug Contamination; Drug Industry; Eosinophilia-Myalgia Syndrome; Humans; Melatonin | 1997 |
Structural characterization of contaminants found in commercial preparations of melatonin: similarities to case-related compounds from L-tryptophan associated with eosinophilia-myalgia syndrome.
Topics: Chromatography, High Pressure Liquid; Disease Outbreaks; Drug Contamination; Eosinophilia-Myalgia Sy | 1998 |
Over-the-counter melatonin products and contamination.
Topics: Drug Contamination; Eosinophilia-Myalgia Syndrome; Gas Chromatography-Mass Spectrometry; Humans; Mel | 1999 |